...
首页> 外文期刊>EXCLI Journal >Roles of kininogen-1, basement membrane specific heparan sulfate proteoglycan core protein, and roundabout homolog 4 as potential urinary protein biomarkers in diabetic nephropathy
【24h】

Roles of kininogen-1, basement membrane specific heparan sulfate proteoglycan core protein, and roundabout homolog 4 as potential urinary protein biomarkers in diabetic nephropathy

机译:Kininogen-1,基底膜特异性硫酸盐蛋白多糖核糖蛋白和环形交叉同源物4的作用作为糖尿病肾病的潜在尿蛋白生物标志物

获取原文
           

摘要

Diabetic nephropathy, a major complication of diabetes mellitus (DM), is increasing worldwide and the large majority of patients have type 2 DM. Microalbuminuria has been used as a diagnostic marker of diabetic nephro-pathy. But owing to its insufficient sensitivity and specificity, other biomarkers are being sought. In addition, the pathophysiology of diabetic nephropathy is not fully understood and declines in renal function occur even without microalbuminuria. In this study, we investigated urinary proteins from three study groups (controls, and type 2 diabetic subjects with or without microalbuminuria). Non-targeted label-free Nano-LC QTOF analysis was conducted to discover underlying mechanisms and protein networks, and targeted label-free Nano-LC QTOF with SWATH was performed to qualify discovered protein candidates. Twenty-eight proteins were identified as candidates and functionally analyzed via String DB, gene ontology and pathway analysis. Four predictive mechanisms were analyzed: i) response to stimulus, ii) platelet activation, signaling and aggregation, iii) ECM-receptor interaction, and iv) angiogenesis. These mechanisms can provoke kidney dysfunction in type 2 diabetic patients via endothelial cell damage and glomerulus structural alteration. Based on these analyses, three proteins (kininogen-1, basement membrane-specific heparan sulfate proteoglycan core protein, and roundabout homolog 4) were proposed for further study as potential biomarkers. Our findings provide insights that may improve methods for both prevention and diagnosis of diabetic nephropathy.
机译:糖尿病肾病,糖尿病(DM)的主要并发症,在全球范围内增加,大多数患者有2 DM。微蛋氨酸被用作糖尿病肾病的诊断标记。但由于其敏感性和特异性不足,正在寻求其他生物标志物。此外,糖尿病肾病的病理生理学尚未完全理解,肾功能下降甚至没有微白蛋氨酸发生。在这项研究中,我们研究了来自三个研究组(对照组和2型糖尿病受试者的尿蛋白,有或没有微蛋氨酸)。进行非靶标无标记的纳米LC QTOF分析以发现潜在的机制和蛋白质网络,并进行靶向无标记的纳米LC QTOF,用于鉴定发现的蛋白质候选物。将二十八种蛋白质被鉴定为候选物,通过串DB,基因本体和途径分析来用功能分析。分析了四种预测机制:i)响应刺激,ii)血小板活化,信号传导和聚集,III)ECM-受体相互作用和IV)血管生成。这些机制可以通过内皮细胞损伤和肾小球结构改变来引发2型糖尿病患者的肾功能障碍。基于这些分析,提出了三种蛋白质(活性-1,基底膜特异性硫酸乙酰丙酸核糖甘露糖核糖核核糖蛋白,以及环形交叉同源物4),以进一步研究作为潜在的生物标志物。我们的调查结果提供了可能改善预防和诊断糖尿病肾病的方法的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号